Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Marcault C, Zhao LP, Maslah N, Verger E, et al. Blood 2021;138:2142-2148.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marcault C, Zhao LP, Maslah N, Verger E, et al. Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood 2021;138:2142-2148.
PMID: 33945619